Medical Xpress news

Medical Xpress / A 'one-two punch' against aggressive breast cancer could offer an alternative to chemotherapy

Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease ...

Aug 31, 2026
Medical Xpress / Cancer's malignant remote control: How tumors reprogram liver fat metabolism to disarm immune cells

In their quest to understand how cancers take root, grow and spread, scientists have for the past half-century explored the genetic aberrations and microenvironmental peculiarities of tumors and their constituent cells. Such ...

Aug 31, 2026
Medical Xpress / Potent antiplatelet drugs increase major bleeding risk in AF patients after heart attack

Potent antiplatelet therapy increased bleeding without signs of benefit regarding cardiovascular events in patients with atrial fibrillation after a heart attack. This was the main finding of the EPIDAURUS trial presented ...

Aug 31, 2026
Medical Xpress / When danger becomes familiar, falling dopamine may free mice to pursue rewards

When an animal encounters a potential threat in its environment, it must focus completely on the danger to protect itself. But with repeated exposure, the threat becomes familiar and less important. The animal learns to adapt ...

Aug 31, 2026
Medical Xpress / Targeting protein synthesis control regions may reduce seizures in genetic epilepsy

Targeting the control of protein synthesis in the KCNQ2 gene may serve as a potential disease-modifying strategy for patients with a genetic form of neonatal-onset epilepsy and impaired brain development, according to a Northwestern ...

Aug 31, 2026
Medical Xpress / Hidden immune cells in the lung could lead to better flu vaccines

Influenza continues to cause major illness each year in the United States, leading to more than 35,000 deaths annually. Children, older adults, pregnant individuals, people with weakened immune systems and those with chronic ...

Aug 31, 2026
Medical Xpress / GLP-1s do not cause major psychiatric harm, according to new study

There is no link between the widely used diabetes and obesity medications known as GLP-1 receptor agonists and increased suicidal thoughts, depression or other serious psychiatric harm, based on an integrative review of current ...

Aug 31, 2026
Medical Xpress / Scientists identify genes that could reduce APOE4 Alzheimer's disease risk

An international team of researchers led by Michael E. Belloy, Ph.D., an assistant professor of neurology and psychiatry at WashU Medicine, identified key genetic targets for developing potential Alzheimer's disease therapeutics. ...

Aug 31, 2026
Medical Xpress / Extended Paxlovid fails to ease long COVID symptoms in 959-person trial

Results from a clinical trial and published today in the journal Lancet Infectious Diseases show that the antiviral drug Paxlovid, commonly prescribed to treat acute COVID-19, does not affect long COVID symptoms compared ...

Aug 31, 2026
Medical Xpress / Most women wear shoes that don't match their feet, study finds

Most women in a new RMIT University study wore shoe sizes that differed from the size indicated by their foot length, highlighting the limitations of conventional sizing systems in accounting for differences in foot width ...

Aug 31, 2026
Medical Xpress / New AI method can support real-time management of infectious diseases

For the past 25 years, one discipline has been revolutionizing epidemiology: phylodynamics. By using genetic sequences, scientists can study how pathogens evolve. Thanks to mathematics, these data can be coherently organized ...

Aug 31, 2026
Medical Xpress / Four disease profiles reveal uneven benefits from lifestyle programs after age 70

Older adults living with several chronic diseases, a condition known as multimorbidity, may respond differently to interventions aimed at preventing disability, depending on the combination of diseases they have. A new study, ...

Aug 31, 2026